JP2022069437A - 医薬製剤およびその製造方法 - Google Patents

医薬製剤およびその製造方法 Download PDF

Info

Publication number
JP2022069437A
JP2022069437A JP2021174126A JP2021174126A JP2022069437A JP 2022069437 A JP2022069437 A JP 2022069437A JP 2021174126 A JP2021174126 A JP 2021174126A JP 2021174126 A JP2021174126 A JP 2021174126A JP 2022069437 A JP2022069437 A JP 2022069437A
Authority
JP
Japan
Prior art keywords
pharmaceutical preparation
nuclear
volatile solvent
preparation according
nuclear particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021174126A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022069437A5 (enExample
Inventor
俊行 稲田
Toshiyuki Inada
良成 金山
Yoshinari Kanayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Pharma Co Ltd
Original Assignee
Fuji Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Pharma Co Ltd filed Critical Fuji Pharma Co Ltd
Publication of JP2022069437A publication Critical patent/JP2022069437A/ja
Publication of JP2022069437A5 publication Critical patent/JP2022069437A5/ja
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2021174126A 2020-10-23 2021-10-25 医薬製剤およびその製造方法 Pending JP2022069437A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020178400 2020-10-23
JP2020178400 2020-10-23

Publications (2)

Publication Number Publication Date
JP2022069437A true JP2022069437A (ja) 2022-05-11
JP2022069437A5 JP2022069437A5 (enExample) 2024-10-29

Family

ID=81521745

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021174126A Pending JP2022069437A (ja) 2020-10-23 2021-10-25 医薬製剤およびその製造方法

Country Status (1)

Country Link
JP (1) JP2022069437A (enExample)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006160730A (ja) * 2004-11-12 2006-06-22 Taisho Pharmaceut Co Ltd 低融点薬物含有粉粒体及びその製造方法
JP2007528389A (ja) * 2004-03-10 2007-10-11 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 安定化した過飽和固体親油性薬物
JP2010065023A (ja) * 2008-08-14 2010-03-25 Lion Corp 脂溶性ビタミンおよび／または脂溶性色素含有粉体
WO2016194805A1 (ja) * 2015-05-30 2016-12-08 富田製薬株式会社 油状物質含有粉末組成物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007528389A (ja) * 2004-03-10 2007-10-11 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 安定化した過飽和固体親油性薬物
JP2006160730A (ja) * 2004-11-12 2006-06-22 Taisho Pharmaceut Co Ltd 低融点薬物含有粉粒体及びその製造方法
JP2010065023A (ja) * 2008-08-14 2010-03-25 Lion Corp 脂溶性ビタミンおよび／または脂溶性色素含有粉体
WO2016194805A1 (ja) * 2015-05-30 2016-12-08 富田製薬株式会社 油状物質含有粉末組成物

Similar Documents

Publication Publication Date Title
JP6560289B2 (ja) 新たな医薬組成物
JP6259490B2 (ja) ベンダムスチンの経口投与形及びその治療的使用
AU2013361292A1 (en) Supersaturated stabilized nanoparticles for poorly soluble drugs
WO2020044314A1 (en) Vitamin d pediatric dosage forms, methods of making and using
CN107812195B (zh) (6s)‐5‐甲基‐四氢叶酸钙盐的稳定药物组合物
AU2008215659B2 (en) Pharmaceutical composition comprising microparticle oily suspension
AU2006240551A1 (en) Pharmaceutical dosage forms comprising a lipid phase
JP2019163327A (ja) 三種混合製剤
US20140044780A1 (en) Extended-Release Levetiracetam and Method of Preparation
WO2021151168A1 (en) Method of cannabinoid therapy
JP6374879B2 (ja) 骨粗しょう症治療用の安定な医薬組成物
JP7640453B2 (ja) 医薬製剤およびその製造方法
TWI829920B (zh) 醫藥製劑及其之製造方法
JP2022069437A (ja) 医薬製剤およびその製造方法
KR20060056320A (ko) 사퀴나비르 메실레이트 경구 투여 형태
JP5774308B2 (ja) 水溶性ビノレルビン塩の安定な医薬組成物
JP2014530828A (ja) 有機化合物におけるまたは有機化合物に関連する改善
WO2018130943A1 (en) Oral pharmaceutical composition of lurasidone and preparation thereof
JP2024524757A (ja) 多粒子医薬組成物
TW201538159A (zh) 用於治療高膽固醇血症、高脂蛋白血疾病或動脈粥樣硬化之醫藥組合物及其製備方法
WO2008152598A1 (en) Stabilized pharmaceutical compositions comprising atorvastatin
HK1179859B (en) Oral dosage forms of bendamustine and therapeutic use thereof
CN104363898A (zh) [(1s)-1-{[(2s,4r)-4-(7-氯-4-甲氧基异喹啉-1-基氧基)-2-({(1r,2s)-1-[(环丙基磺酰基)氨甲酰基]-2-乙烯基环丙基}氨甲酰基)吡咯烷-1-基]羰基}-2,2-二甲基丙基]氨基甲酸1,1-二甲基乙基酯的口服固体给药制剂

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20211112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241021

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241021

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20250522

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251209